Krystal Biotech, Inc. (KRYS)
253.68
+1.51
(+0.60%)
USD |
NASDAQ |
Dec 29, 16:00
253.67
-0.01
(-0.00%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Quarterly): 1.138B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DexCom, Inc. | 2.726B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| ADMA Biologics, Inc. | 431.19M |
| Aldeyra Therapeutics, Inc. | 49.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.240B |
| Total Liabilities (Quarterly) | 102.22M |
| Debt to Equity Ratio | 0.0084 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | -0.01% |